BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED
64 results:

  • 1. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
    Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
    Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1.
    Zhang Z; Song B; Wei H; Liu Y; Zhang W; Yang Y; Sun B
    Drug Resist Updat; 2024 Mar; 73():101040. PubMed ID: 38228036
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3-IFIT3 axis.
    Hu H; Li B; Chen H; Fan G; Ye Z; Ji S; Yu X; Xu X; Qin Y
    Mol Carcinog; 2024 Feb; 63(2):195-208. PubMed ID: 37846815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in pancreatic cancer: A Bayesian Network Meta-Analysis.
    Aryanti C; Uwuratuw JA; Labeda I; Raharjo W; Lusikooy RE; Rauf MA; Mappincara A; Sampetoding S; Kusuma MI; Syarifuddin E
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2895-2902. PubMed ID: 37642079
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
    Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Repurposing a plant alkaloid homoharringtonine targets insulinoma associated-1 in n-myc-activated neuroblastoma.
    Chen C; Wu J; Hicks C; Lan MS
    Cell Signal; 2023 Sep; 109():110753. PubMed ID: 37301315
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The deubiquitinase USP28 maintains the expression of the transcription factor mycn and is essential in neuroblastoma cells.
    Li J; Peng J; Wu L; Shen X; Zhen X; Zhang Y; Ma H; Xu Y; Xiong Q; Zhu Q; Zhang P
    J Biol Chem; 2023 Jul; 299(7):104856. PubMed ID: 37230388
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clonal evolution during metastatic spread in high-risk neuroblastoma.
    Gundem G; Levine MF; Roberts SS; Cheung IY; Medina-Martínez JS; Feng Y; Arango-Ossa JE; Chadoutaud L; Rita M; Asimomitis G; Zhou J; You D; Bouvier N; Spitzer B; Solit DB; Dela Cruz F; LaQuaglia MP; Kushner BH; Modak S; Shukla N; Iacobuzio-Donahue CA; Kung AL; Cheung NV; Papaemmanuil E
    Nat Genet; 2023 Jun; 55(6):1022-1033. PubMed ID: 37169874
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
    Brogyányi T; Kaplánek R; Kejík Z; Hosnedlová B; Antonyová V; Abramenko N; Veselá K; Martásek P; Vokurka M; Richardson DR; Jakubek M
    Biomed Pharmacother; 2022 Nov; 155():113736. PubMed ID: 36156366
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Thiosemicarbazones reprogram pancreatic cancer bidirectional oncogenic signaling between cancer cells and stellate cells to suppress desmoplasia.
    Richardson DR; Azad MG; Afroz R; Richardson V; Dharmasivam M
    Future Med Chem; 2022 Jul; 14(13):1005-1017. PubMed ID: 35670251
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network.
    Wang Z; Zhang S
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212175
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo.
    Dubiella C; Pinch BJ; Koikawa K; Zaidman D; Poon E; Manz TD; Nabet B; He S; Resnick E; Rogel A; Langer EM; Daniel CJ; Seo HS; Chen Y; Adelmant G; Sharifzadeh S; Ficarro SB; Jamin Y; Martins da Costa B; Zimmerman MW; Lian X; Kibe S; Kozono S; Doctor ZM; Browne CM; Yang A; Stoler-Barak L; Shah RB; Vangos NE; Geffken EA; Oren R; Koide E; Sidi S; Shulman Z; Wang C; Marto JA; Dhe-Paganon S; Look T; Zhou XZ; Lu KP; Sears RC; Chesler L; Gray NS; London N
    Nat Chem Biol; 2021 Sep; 17(9):954-963. PubMed ID: 33972797
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma.
    Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z
    FASEB J; 2021 Feb; 35(2):e21347. PubMed ID: 33484481
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
    Viúdez A; Crespo G; Gómez Dorronsoro ML; Arozarena I; Marín-Méndez JJ; Custodio A; Benavent M; Goñi S; García-Paredes B; Hernando J; Durantez M; Alonso V; Riesco MDC; López C; Jiménez-Fonseca P; San Vicente BL; González-Borja I; Sevilla I; Hernández-Garcia I; Carmona-Bayonas A; Capdevila J; Pérez-Sanz J; García-Carbonero R; Pérez-Ricarte L; Llanos M; Vera R; De Jesús Acosta A
    Pancreatology; 2021 Jan; 21(1):215-223. PubMed ID: 33358592
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function.
    Shi HH; Liu HE; Luo XJ
    BMB Rep; 2020 Dec; 53(12):658-663. PubMed ID: 33298240
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
    Tolosa EJ; Fernandez-Barrena MG; Iguchi E; McCleary-Wheeler AL; Carr RM; Almada LL; Flores LF; Vera RE; Alfonse GW; Marks DL; Hogenson TL; Vrabel AM; Horn IP; Koenig AN; Safgren SL; Sigafoos AN; Erkan M; Romecin-Duran PA; Sarabia Gonzalez A; Zhou B; Javelaud D; Marsaud V; Graham RP; Mauviel A; Elsawa SF; Fernandez-Zapico ME
    Biochem J; 2020 Sep; 477(17):3131-3145. PubMed ID: 32766732
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
    Sahni S; Gillson J; Park KC; Chiang S; Leck LYW; Jansson PJ; Richardson DR
    Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129625. PubMed ID: 32335136
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Primary pancreatic Neuroblastoma in an Infant.
    Morrison ZD; Sun Y; Manalang M; Dominguez K
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e541-e543. PubMed ID: 31688624
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
    Han L; Zan Y; Huang C; Zhang S
    Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Investigating the Contribution of Collagen to the Tumor Biomechanical Phenotype with Noninvasive Magnetic Resonance Elastography.
    Li J; Zormpas-Petridis K; Boult JKR; Reeves EL; Heindl A; Vinci M; Lopes F; Cummings C; Springer CJ; Chesler L; Jones C; Bamber JC; Yuan Y; Sinkus R; Jamin Y; Robinson SP
    Cancer Res; 2019 Nov; 79(22):5874-5883. PubMed ID: 31604713
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.